Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
-
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden is zeroing in on the policy goals closest to his heart…
-
Artificial Intelligence | Biotechnology | Diagnostics | Medicine | Non-Profit Research | Therapeutics
HHMI Invested $500 Million in AI-Driven Life Sciences Research
On Aug. 12, 2024, The Howard Hughes Medical Institute (HHMI) announced AI@HHMI, a $500 million investment over the…
-
Largest Protein Yet Discovered Builds Algal Toxins
On Aug. 8, 2024, scientists at UC San Diego’s Scripps Institution of Oceanography announced they had discovered the…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
Amneal Received U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
-
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Therapeutics
FDA Approved ‘First Gene Therapy’ to Treat Adults with Metastatic Synovial Sarcoma
On Aug. 2, 2024, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra (afamitresgene autoleucel), a gene therapy…
-
the Lancet standing Commission Report: Dementia prevention, intervention, and care released
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
-
Cannabinoid CBG reduced anxiety and stress in first human clinical trial
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
-
Generation X and Millennials in U.S. Have Higher Risk of Developing 17 Cancers Compared to Older Generations
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
Alpha Cognition’s Oral Therapy ZUNVEYL® Receives FDA Approval to Treat Alzheimer’s Disease
On Jul. 29, 2024, announces that the U.S. Food and Drug Administration (FDA) has granted approval for ZUNVEYL®…
-
largest population-based study to date supported the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer
On Jul. 29, 2024, a team led by Dipesh Uprety, M.D., FACP, of the Barbara Ann Karmanos Cancer…
-
Maryland Department of Health issued consumer advisory for Boar’s Head liverwurst and other deli meat products due to possible Listeria contamination
On Jul. 26, 2024, the Maryland Department of Health advised consumers not to eat certain deli meats produced…
-
Boar’s Head Recalls Ready-To-Eat Liverwurst And Other Deli Meat Products Due to Possible Listeria Contamination
On Jul. 26. 2024, Boar’s Head, a Jarratt, Va., establishment, announced it was recalling all liverwurst product produced…
-
European Commission Approved Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
-
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
-
Biotechnology | Disease | HIV | Therapeutics | WHO
A seventh case of HIV cure reported
On Jul. 25, 2024, the World Health Organization (WHO) announced during the 25th International AIDS Conference, being held…
-
CIRM approved $8 million award for plasma cell disorder therapy, $27 million to boost collaboration among California researchers
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
-
CDC reported Listeria Outbreak Linked to Meats Sliced at Delis
On Jul. 19, 2024, the Centers for Disease Control and Prevention (CDC) announced that it had begun an…
-
Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs
On Jul. 16, 2024, the University of Hong Kong released a study that showed hospitalized COVID-19 patients treated…
-
Supplements slow disease progression during late stage of “dry” age-related macular degeneration
On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking…
-
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
-
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
-
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
-
Disease | Therapeutics | WHO
WHO releases first-ever clinical treatment guideline for tobacco cessation in adults
On Jul. 2, 2024, the World Health Organization (WHO) recommended a comprehensive set of tobacco cessation interventions, including…
-
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
-
FDA Permited Marketing of First Point-of-Care Hepatitis C RNA Test
On Jun. 27, 2024, the U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the…
-
NIAID Discovery Leads to Novel Probiotic for Eczema
On Jun. 26, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) announced that research has led…
-
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
-
Biotechnology | CDC | Therapeutics | Vaccine
CDC Updated RSV Vaccination Recommendation for Adults
On Jun. 26, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendation for the…
-
Biotechnology | Influenza | Therapeutics | USDA | Vaccine | Veterinary
USDA Approved Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
